RELATING TO UNIVERSAL IMMUNIZATION FUNDING PROGRAM.
HB1115 establishes a Universal Immunization Funding Program within the Department of Health and creates a Universal Immunization Purchase Special Fund to finance the state purchase and distribution of immunizations. The bill is modeled on “universal purchase” or “universal select” programs used in other states, where the state buys vaccines at discounted federal contract prices and makes them available to providers at no cost for eligible populations not already covered by other public programs. It defines covered children and adults, identifies the insurers and health plans that would be assessed, and authorizes the department to maintain a list of immunizations and brand choices funded under the program.
The bill would require assessed health carriers and related entities to report covered lives and pay per-member-per-month assessments calculated by the Department of Health to cover vaccine acquisition, administration costs of the program, reserves, and working capital. It also allows interim assessments for new immunizations or public health emergencies, imposes reporting and audit obligations, and authorizes civil penalties for noncompliance. The measure includes appropriations for startup operations and initial procurements and states that providers may not bill assessed entities or others for immunizations supplied at no cost by the state, while provider administration fees are not changed.
If enacted, HB1115 would add a new part to chapter 321, Hawaii Revised Statutes, creating a state-run vaccine purchasing and funding structure administered by the Department of Health. It would shift vaccine procurement for covered populations away from fragmented private purchasing toward a centralized state fund supported by assessments on certain insurers, health maintenance organizations, mutual benefit societies, fraternal benefit societies, and potentially other health cost-sharing arrangements. The bill also interacts with Hawaii’s immunization registry requirements and would give the department rulemaking, audit, enforcement, and refund authority tied to the program.
The bill appears to have mixed but generally serious consideration: it advanced on second reading and was referred onward, but the vote was split, with some members voting aye with reservations and several voting no. That pattern suggests support for the public health goals of improving vaccine access and preparedness, alongside concerns about the financing mechanism, administrative burden, or the scope of the new assessments. The bill text itself frames the program as a public health investment intended to reduce provider costs and improve emergency supply responsiveness.
The main points of contention are likely the mandatory assessments on insurers and related health entities, the breadth of the entities included, and the potential cost impact on the private insurance market and self-insured arrangements. Another likely issue is administrative complexity, including reporting covered lives, audits, penalties, and how the Department of Health would set and adjust assessment rates. The “aye with reservations” votes and the no votes indicate that while the public health rationale may be broadly recognized, some legislators were not fully comfortable with the funding structure, implementation details, or fiscal exposure created by the program.